12:11:22 EDT Mon 06 Jul 2020
Enter Symbol
or Name
USA
CA



Login ID:
Password:
Save
Liminal Biosciences Inc
Symbol LMNL
Shares Issued 23,420,352
Close 2020-06-30 C$ 14.24
Recent Sedar Documents

Liminal seeks plasma from COVID-19 survivors

2020-06-30 17:56 ET - News Release

Mr. Kenneth Galbraith reports

LIMINAL BIOSCIENCES COMMENCES COLLECTION OF CONVALESCENT PLASMA FROM COVID-19 RECOVERED DONORS

Prometic Plasma Resources, a subsidiary of Liminal Biosciences Inc., has commenced the collection of convalescent plasma from donors who have recovered from COVID-19.

"Recent published studies have indicated immune globulin and hyperimmune globulin therapy to have the potential to be one of the treatment options for patients with COVID-19. We are proud to be collecting COVID-19 convalescent plasma to be potentially used in the manufacture of hyperimmune immunoglobulins by third parties and be a part of this historic effort which aims to accelerate a reliable, scalable and sustainable option for patients suffering from the impact of COVID-19," stated Kenneth Galbraith, chief executive officer of Liminal Biosciences. "We expect that developing a hyperimmune will require third parties to collect plasma donations from many individuals who have fully recovered from COVID-19, and we encourage anyone who has recovered from COVID-19 without symptoms for 14 days to come forward and donate plasma to this worthy cause."

Individuals interested in donating plasma can visit the nearest licensed plasma collection centre to their location. For more information, visit Prometic Plasma's website.

About Liminal Biosciences Inc.

Liminal Biosciences is a clinical-stage biopharmaceutical company focused on discovering, developing and commercializing novel treatments for patients suffering from diseases related to fibrosis, including respiratory, liver and kidney diseases that have high unmet medical need.

We seek Safe Harbor.

© 2020 Canjex Publishing Ltd. All rights reserved.